ARCHIVES

Feds Set Guidelines For Pharma To Help Patients With Cost Of Drugs, While Steering Clear Of Anti-Kickback Law.

This article is from The Cancer Letter archive.

Vol. 32 No. 16 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

Wyden Asks Bristol For documentation To Prove That Taxol Price Is Not “Gouging” Taxpayers

January 29, 1993

NCAB Oks Organ Systems Plan, Criteria For Starting, Ending Working Groups

October 7, 1988

M.D. Anderson Must Evaluate 8 Patients In Controversial Study

May 31, 1996

Celgene Signs CRADA With NCI For Development Of CDC-501.

June 30, 2000

Mammography Debate “Confused a Whole Generation” – Shalala

January 7, 1994

NCI Bypass Budget Seeks $3.64 Billion

January 20, 1995